Squarepoint’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $729K | Buy |
+101,518
| New | +$729K | ﹤0.01% | 1694 |
|
|
2025
Q1 | – | Sell |
-128,799
| Closed | -$1M | – | 2830 |
|
|
2024
Q4 | $1M | Buy |
128,799
+117,939
| +1,086% | +$920K | ﹤0.01% | 1530 |
|
|
2024
Q3 | $117K | Buy |
+10,860
| New | +$117K | ﹤0.01% | 2308 |
|
|
2024
Q2 | – | Sell |
-16,843
| Closed | -$113K | – | 2556 |
|
|
2024
Q1 | $113K | Buy |
16,843
+566
| +3% | +$3.8K | ﹤0.01% | 2233 |
|
|
2023
Q4 | $95.7K | Buy |
+16,277
| New | +$95.7K | ﹤0.01% | 2279 |
|
|
2023
Q2 | – | Sell |
-25,958
| Closed | -$280K | – | 2454 |
|
|
2023
Q1 | $280K | Sell |
25,958
-37,192
| -59% | -$401K | ﹤0.01% | 1715 |
|
|
2022
Q4 | $730K | Buy |
+63,150
| New | +$730K | ﹤0.01% | 1266 |
|
|
2022
Q1 | – | Sell |
-10,475
| Closed | -$90K | – | 2316 |
|
|
2021
Q4 | $90K | Buy |
+10,475
| New | +$90K | ﹤0.01% | 2331 |
|
|
2021
Q2 | – | Sell |
-10,290
| Closed | -$90K | – | 2673 |
|
|
2021
Q1 | $90K | Sell |
10,290
-1,982
| -16% | -$17.3K | ﹤0.01% | 2377 |
|
|
2020
Q4 | $138K | Sell |
12,272
-12,067
| -50% | -$136K | ﹤0.01% | 2258 |
|
|
2020
Q3 | $228K | Buy |
+24,339
| New | +$228K | ﹤0.01% | 1856 |
|
|
2018
Q4 | – | Sell |
-4,850
| Closed | -$200K | – | 1964 |
|
|
2018
Q3 | $200K | Buy |
+4,850
| New | +$200K | ﹤0.01% | 1769 |
|